Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Mudane A -----Limfooma-ka Unugga B-ga Weyn (DLBCL)

Magaca: Mudane A

Jinsiga: Lab

Da'da: 66

Jinsiyadda: Hindiya

Baadhista: Lymphoma-ka Unugga B-ga ee Diffuse Large (DLBCL)

    Mudane A, oo asal ahaan ka soo jeeda Hindiya, oo ah qof firfircoon oo 66 jir ah, ayaa safarkiisa caafimaad bilaabay bishii Abriil 2018. Ka dib markii la baaray tiro ku jirta gacantiisa bidix, iyo sawir PET-CT oo dhammaystiran oo jirka oo dhan ah, waxaa la ogaaday in Diffuse Large B-Cell Lymphoma (DLBCL) la sameeyay. Tani waxay calaamad u ahayd bilowga nidaam daaweyn oo adag oo loogu talagalay la dagaallanka cudurka.

    Markii hore, Mr. A, oo markii hore marayay lix wareeg oo ah nidaamka kiimoterabiga ee R-EPOCH, wuxuu markii dambe u wareegay saddex wareeg oo nidaamka R-GDP ah, ka dibna laba wareeg oo dheeraad ah oo isku mid ah. Nidaamkan kiimoterabiga ee degdegga ah wuxuu socday laga bilaabo Abriil 2018 ilaa Oktoobar 2019, muddo lagu garto dulqaad iyo adkeysi marka la wajahayo dhibaatooyinka.

    Iyadoo ay jirto daaweyn adag, haddana waxaa soo ifbaxay dib-u-eegis PET-CT Oktoobar 2019, taasoo shaaca ka qaadaysa cillado cusub oo dheef-shiid kiimikaad ah oo ka jira aagga calcaneus-ka midig iyo femur-ka bidix ee midig. Isagoo aan niyad jabin, Mr. A, oo ku hubaysan aqoonta BIOOCUS Medical Group oo ah xarunta ugu horreysa ee CAR-T adduunka oo dhan, ayaa raadiyay khibraddeeda.

    Noofambar 2019 waxay calaamad u ahayd isbeddel muhiim ah markii Mr. A uu bilaabay marxalad cusub oo daaweyn ah oo ay daryeelayaan kooxdeenna caafimaad. Baaritaanno dhammaystiran ayaa lagu ogaaday CD19 oo ah mid aan wanaagsanayn iyo CD22 oo aad u xooggan, taasoo muujinaysa firfircooni burooyinka haray oo badan. Marka la eego natiijooyinkan, waxaa la go'aansaday in la sii wado daaweynta unugyada CAR-T ee CD19+CD22, oo ah hab casri ah oo loogu talagalay in wax looga qabto kansarka joogtada ah.

    Ka dib markii la geliyay, Mr. A wuxuu la kulmay cudurka 'degree 2 Cytokine Release Syndrome' (CRS), isagoo si dhakhso ah u bogsanaya ka dib. Janaayo 2020, waa la sii daayay, iyadoo ay ku qanceen natiijooyin rajo leh oo ka soo baxay sawirkii ugu dambeeyay ee PET-CT oo muujinaya dib-u-noqoshada burooyinka iyo hoos u dhac weyn oo ku yimid dhaqdhaqaaqa dheef-shiid kiimikaadka.

    Safarka Mudane A wuxuu u adeegaa sidii iftiin rajo, isagoo hoosta ka xariiqaya awoodda isbeddelka ee faragelinta caafimaad ee horumarsan ee ku aaddan cudurka kansarka. Markuu bilaabayo daaweyn bukaan-socod oo muddo dheer ah, diiradda ayaa saaran sidii loo ilaalin lahaa firfircoonida cusub iyo ka hortagga soo noqoshada cudurka.

    sharraxaad2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write